A detailed history of Lsv Asset Management transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Lsv Asset Management holds 8,280,905 shares of BMY stock, worth $440 Million. This represents 0.75% of its overall portfolio holdings.

Number of Shares
8,280,905
Previous 8,532,241 2.95%
Holding current value
$440 Million
Previous $463 Million 25.67%
% of portfolio
0.75%
Previous 0.96%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 06, 2024

SELL
$40.25 - $52.99 $10.1 Million - $13.3 Million
-251,336 Reduced 2.95%
8,280,905 $344 Million
Q1 2024

May 06, 2024

SELL
$47.98 - $54.4 $9.75 Million - $11.1 Million
-203,222 Reduced 2.33%
8,532,241 $463 Million
Q4 2023

Feb 06, 2024

SELL
$48.48 - $57.85 $12.7 Million - $15.1 Million
-261,300 Reduced 2.9%
8,735,463 $448 Million
Q3 2023

Nov 03, 2023

SELL
$57.89 - $64.73 $23.3 Million - $26 Million
-401,892 Reduced 4.28%
8,996,763 $522 Million
Q2 2023

Aug 02, 2023

SELL
$63.71 - $70.74 $177,177 - $196,727
-2,781 Reduced 0.03%
9,398,655 $601 Million
Q1 2023

May 02, 2023

SELL
$65.71 - $74.53 $2.85 Million - $3.23 Million
-43,401 Reduced 0.46%
9,401,436 $652 Million
Q4 2022

Feb 08, 2023

SELL
$68.48 - $81.09 $32.5 Million - $38.5 Million
-474,618 Reduced 4.78%
9,444,837 $680 Million
Q3 2022

Nov 07, 2022

SELL
$0.13 - $76.84 $7,383 - $4.36 Million
-56,798 Reduced 0.57%
9,919,455 $705 Million
Q2 2022

Aug 10, 2022

SELL
$72.62 - $79.98 $18.9 Million - $20.9 Million
-260,793 Reduced 2.55%
9,976,253 $768 Million
Q1 2022

May 12, 2022

BUY
$61.48 - $73.72 $4.68 Million - $5.62 Million
76,197 Added 0.75%
10,237,046 $748 Million
Q4 2021

Jan 28, 2022

SELL
$53.63 - $62.52 $16.8 Million - $19.5 Million
-312,640 Reduced 2.99%
10,160,849 $634 Million
Q3 2021

Nov 04, 2021

SELL
$59.17 - $69.31 $10.1 Million - $11.9 Million
-171,154 Reduced 1.61%
10,473,489 $620 Million
Q2 2021

Aug 04, 2021

BUY
$61.91 - $67.42 $5.53 Million - $6.02 Million
89,320 Added 0.85%
10,644,643 $711 Million
Q1 2021

Apr 30, 2021

SELL
$59.34 - $66.74 $32.3 Million - $36.3 Million
-544,265 Reduced 4.9%
10,555,323 $666 Million
Q4 2020

Feb 08, 2021

SELL
$57.74 - $65.43 $27.6 Million - $31.2 Million
-477,214 Reduced 4.12%
11,099,588 $689 Million
Q3 2020

Oct 23, 2020

BUY
$57.43 - $63.64 $14.5 Million - $16.1 Million
253,311 Added 2.24%
11,576,802 $698 Million
Q2 2020

Aug 05, 2020

BUY
$54.82 - $64.09 $85.2 Million - $99.6 Million
1,553,690 Added 15.9%
11,323,491 $666 Million
Q1 2020

May 07, 2020

BUY
$46.4 - $67.43 $1.43 Million - $2.07 Million
30,757 Added 0.32%
9,769,801 $545 Million
Q4 2019

Feb 10, 2020

BUY
$49.21 - $64.19 $291 Million - $379 Million
5,908,344 Added 154.24%
9,739,044 $625 Million
Q3 2019

Nov 07, 2019

BUY
$42.77 - $50.71 $157 Million - $186 Million
3,662,100 Added 2172.06%
3,830,700 $194 Million
Q4 2018

Feb 05, 2019

BUY
$48.76 - $63.23 $6.41 Million - $8.31 Million
131,469 Added 354.07%
168,600 $8.76 Million
Q3 2018

Nov 06, 2018

BUY
$55.19 - $62.25 $1.56 Million - $1.76 Million
28,231 Added 317.2%
37,131 $2.31 Million
Q2 2018

Aug 08, 2018

BUY
$50.53 - $62.98 $449,717 - $560,522
8,900 New
8,900 $492,000
Q4 2017

Feb 01, 2018

SELL
$59.94 - $65.35 $479,520 - $522,799
-8,000 Closed
0 $0
Q3 2017

Nov 13, 2017

BUY
$55.23 - $63.74 $441,840 - $509,920
8,000
8,000 $509,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $113B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Lsv Asset Management Portfolio

Follow Lsv Asset Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lsv Asset Management, based on Form 13F filings with the SEC.

News

Stay updated on Lsv Asset Management with notifications on news.